{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:52:26Z","timestamp":1788187946243,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.fct.2025.115351","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:49:26Z","timestamp":1740728966000},"page":"115351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hepatic antifibrotic effects of bezafibrate in vitro and in vivo models of liver fibrosis"],"prefix":"10.1016","volume":"200","author":[{"given":"Camille Kirinus","family":"Reghelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-4663","authenticated-orcid":false,"given":"Matheus Scherer","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"de Souza Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Pasqualotto","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arieli","family":"Cruz de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Andrade","family":"Martha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9ssica Luana","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella Tornquist","family":"Nassr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Claudia","family":"Rosa Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3934-6848","authenticated-orcid":false,"given":"Lucas Strassburger","family":"Matzenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Giancarlo","family":"Schneider Levorse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Theresinha","family":"Costa Rodrigues Guma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-9109","authenticated-orcid":false,"given":"M\u00e1rcio Vin\u00edcius Fagundes","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarbas","family":"Rodrigues de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8574-7741","authenticated-orcid":false,"given":"Denizar","family":"Alberto da Silva Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2025.115351_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2006.11.035","article-title":"Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia","volume":"196","author":"Ayaori","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fct.2025.115351_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.foodchem.2005.07.042","article-title":"Phenolic compounds in plants and agri-industrial by-products: antioxidant activity, occurrence, and potential uses","volume":"99","author":"Balasundram","year":"2006","journal-title":"Food Chem."},{"key":"10.1016\/j.fct.2025.115351_bib3","first-page":"91","article-title":"Therapeutic effect of Baccharis anomala DC. extracts on activated hepatic stellate cells","volume":"18","author":"Basso","year":"2019","journal-title":"EXCLI J"},{"key":"10.1016\/j.fct.2025.115351_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.medcli.2017.08.009","article-title":"Marcadores de fibrosis hep\u00e1tica","volume":"150","author":"Caballer\u00eda","year":"2018","journal-title":"Med. Clin."},{"key":"10.1016\/j.fct.2025.115351_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cmet.2014.08.008","article-title":"When autophagy chaperones liver metabolism","volume":"20","author":"Codogno","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.fct.2025.115351_bib6","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s10637-020-00941-2","article-title":"CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence","volume":"38","author":"da Silva","year":"2020","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.fct.2025.115351_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114433","article-title":"Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-\u0263 and NF-kB mechanism","volume":"280","author":"de Souza Basso","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.fct.2025.115351_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00541","article-title":"Chemical and pharmacological aspects of caffeic acid and its activity in hepatocarcinoma","volume":"9","author":"Esp\u00edndola","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.fct.2025.115351_bib9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.1427","article-title":"The myofibroblast in wound healing and fibrocontractive diseases","volume":"200","author":"Gabbiani","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.fct.2025.115351_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Gracia-Sancho","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.fct.2025.115351_bib11","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.bbadis.2017.05.019","article-title":"Bezafibrate prevents mitochondrial dysfunction, antioxidant system disturbance, glial reactivity and neuronal damage induced by sulfite administration in striatum of rats: implications for a possible therapeutic strategy for sulfite oxidase deficiency","volume":"1863","author":"Grings","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.fct.2025.115351_bib12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1478-3231.2007.01578.x","article-title":"Hepatic stellate cell line modulates lipogenic transcription factors","volume":"27","author":"Guimar\u00e3es","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.fct.2025.115351_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.fct.2025.115351_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.fct.2025.115351_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2018.00150","article-title":"Role of metabolism in hepatic stellate cell activation and fibrogenesis","volume":"6","author":"Hou","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.fct.2025.115351_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10753-019-01142-7","article-title":"p-Coumaric acid attenuates IL-1\u03b2-induced inflammatory responses and cellular senescence in rat chondrocytes","volume":"43","author":"Huang","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.fct.2025.115351_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1139\/cjpp-2020-0159","article-title":"Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats","volume":"99","author":"Ibrahim","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.fct.2025.115351_bib18","doi-asserted-by":"crossref","first-page":"40591","DOI":"10.1074\/jbc.M100975200","article-title":"N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2025.115351_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2007\/71323","article-title":"The role of PPARs in lung fibrosis","volume":"2007","author":"Lakatos","year":"2007","journal-title":"PPAR Res."},{"key":"10.1016\/j.fct.2025.115351_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.fct.2025.115351_bib21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.intimp.2011.12.012","article-title":"Involvement of melatonin in autophagy-mediated mouse hepatoma H22 cell survival","volume":"12","author":"Liu","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.fct.2025.115351_bib22","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2020.01.027","article-title":"Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution","volume":"158","author":"Liu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2025.115351_bib23","article-title":"Chlorogenic acid decreases malignant characteristics of hepatocellular carcinoma cells by inhibiting DNMT1 expression","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fct.2025.115351_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/869390","article-title":"Autophagy: a multifaceted partner in liver fibrosis","author":"Mallat","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.fct.2025.115351_bib25","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","article-title":"Sinusoidal communication in liver fibrosis and regeneration","volume":"65","author":"Marrone","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2025.115351_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5138\/09750185.1832","article-title":"Antifibrotic effect of Pluchea sagitallis (Lam.) cabrera aqueous extract in grx cell lineage","volume":"10","author":"Mendes Ouri","year":"2018","journal-title":"Int. J. Phytomed."},{"key":"10.1016\/j.fct.2025.115351_bib27","doi-asserted-by":"crossref","first-page":"L891","DOI":"10.1152\/ajplung.00333.2007","article-title":"PPAR-\u03b3 agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis","volume":"294","author":"Milam","year":"2008","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.fct.2025.115351_bib28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/hepr.12846","article-title":"Factors predictive of the efficacy of bezafibrate therapy in patients with primary sclerosing cholangitis","volume":"47","author":"Mizuno","year":"2017","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.fct.2025.115351_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003495-198733060-00002","article-title":"Bezafibrate","volume":"33","author":"Monk","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.fct.2025.115351_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2006.02.028","article-title":"Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet","volume":"536","author":"Nagasawa","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fct.2025.115351_bib31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1872-034X.2008.00363.x","article-title":"Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta 1 in a cultured stellate cell line","volume":"38","author":"Nakano","year":"2008","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.fct.2025.115351_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3350\/cmh.2020.0187","article-title":"Anti-fibrotic treatments for chronic liver diseases: the present and the future","volume":"27","author":"Odagiri","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.fct.2025.115351_bib33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00535-006-1778-1","article-title":"Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis","volume":"41","author":"Ohmoto","year":"2006","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.fct.2025.115351_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.fct.2025.115351_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2007-1007128","article-title":"Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis","volume":"19","author":"Pinzani","year":"1999","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.fct.2025.115351_bib36","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.ajpath.2019.07.019","article-title":"Smooth muscle \u03b1-actin deficiency leads to decreased liver fibrosis via impaired cytoskeletal signaling in hepatic stellate cells","volume":"189","author":"Rockey","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.fct.2025.115351_bib37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/antiox10081205","article-title":"Scavenging properties of plant-derived natural biomolecule para-coumaric acid in the prevention of oxidative stress-induced diseases","volume":"10","author":"Roychoudhury","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.fct.2025.115351_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.fct.2025.115351_bib39","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cld.2008.07.004","article-title":"Stellate cell contraction: role, regulation, and potential therapeutic target","volume":"12","author":"Soon","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2025.115351_bib40","doi-asserted-by":"crossref","first-page":"L824","DOI":"10.1152\/ajplung.00350.2015","article-title":"\u03b1-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGF\u03b2 activation or collagen production across multiple models of organ fibrosis","volume":"310","author":"Sun","year":"2016","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.fct.2025.115351_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0021","article-title":"Combination bezafibrate and nivolumab treatment of patients with advanced non\u2013small cell lung cancer","volume":"14","author":"Tanaka","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.fct.2025.115351_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1475-2840-11-140","article-title":"Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?","volume":"11","author":"Tenenbaum","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.fct.2025.115351_bib43","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jhep.2011.07.010","article-title":"A role for autophagy during hepatic stellate cell activation","volume":"55","author":"Thoen","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2025.115351_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00535-008-2181-x","article-title":"Recent advances in the pathogenesis and diagnosis of liver fibrosis","volume":"43","author":"T\u00f6r\u00f6k","year":"2008","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.fct.2025.115351_bib45","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2025.115351_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691525001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691525001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:47:21Z","timestamp":1744886841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691525001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"alternative-id":["S0278691525001188"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2025.115351","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic antifibrotic effects of bezafibrate in vitro and in vivo models of liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2025.115351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115351"}}